Cell mediated immune responses against human prion protein

被引:11
作者
Bainbridge, J [1 ]
Walker, B [1 ]
机构
[1] NIBSC, Div Immunobiol, S Mimms, Herts, England
关键词
prion; vaccination; peptide; CREUTZFELDT-JAKOB-DISEASE; MONOCLONAL-ANTIBODIES; EXPRESSION; TRANSMISSION;
D O I
10.1046/j.1365-2249.2003.02242.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccination approaches that may provide protection against the abnormal form of prion protein (PrPSc) have recently focused on the ability of antibodies to prevent PrPSc propagation. Progress has been hampered due to the difficulty in generating antibody responses in wild type mice, which is believed to be a consequence of T cell tolerance to the normal form of prion protein (PrPc). The problem of tolerance can be avoided using transgenic mice unable to express PrPc. This study examines active PrP specific T cell responses that can be produced in PrP null (PrP 0/0) mice using simple peptide vaccination procedures. Spleenocytes recovered from vaccinated PrP 0/0 mice were tested in vitro for their specificity with T cell recognition demonstrated through a proliferative response to the peptide. Analysis of mRNA also indicates the stimulation of a heterogenous population of T cells with an increase in cytokines and cytotoxicity associated mRNA. Responsive T cells were expanded using a T cell cloning procedure and demonstrated an ability to recognize the mature human prion protein. These clones may potentially be used to negate the problem of T cell tolerance in wild type mice.
引用
收藏
页码:310 / 317
页数:8
相关论文
共 22 条
[1]   Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD [J].
Collinge, J ;
Sidle, KCL ;
Meads, J ;
Ironside, J ;
Hill, AF .
NATURE, 1996, 383 (6602) :685-690
[2]   Variant Creutzfeldt-Jakob disease [J].
Collinge, J .
LANCET, 1999, 354 (9175) :317-323
[3]  
Coulthart MB, 2001, CAN MED ASSOC J, V165, P51
[4]   Prion protein expression in human leukocyte differentiation [J].
Dodelet, VC ;
Cashman, NR .
BLOOD, 1998, 91 (05) :1556-1561
[5]   The epidemiology of variant Creutzfeldt-Jakob disease in Europe [J].
Ghani, AC .
MICROBES AND INFECTION, 2002, 4 (03) :385-393
[6]   Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies [J].
Heppner, FL ;
Musahl, C ;
Arrighi, I ;
Klein, MA ;
Rülicke, T ;
Oesch, B ;
Zinkernagel, RM ;
Kalinke, U ;
Aguzzi, A .
SCIENCE, 2001, 294 (5540) :178-182
[7]   Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples [J].
Hill, AF ;
Butterworth, RJ ;
Joiner, S ;
Jackson, G ;
Rossor, MN ;
Thomas, DJ ;
Frosh, A ;
Tolley, N ;
Bell, JE ;
Spencer, M ;
King, A ;
Al-Sarraj, S ;
Ironside, JW ;
Lantos, PL ;
Collinge, J .
LANCET, 1999, 353 (9148) :183-189
[8]   The same prion strain causes vCJD and BSE [J].
Hill, AF ;
Desbruslais, M ;
Joiner, S ;
Sidle, KCL ;
Gowland, I ;
Collinge, J ;
Doey, LJ ;
Lantos, P .
NATURE, 1997, 389 (6650) :448-450
[9]   Transmission of BSE by blood transfusion in sheep [J].
Houston, F ;
Foster, JD ;
Chong, A ;
Hunter, N ;
Bostock, CJ .
LANCET, 2000, 356 (9234) :999-1000
[10]   Transmission of prion diseases by blood transfusion [J].
Hunter, N ;
Foster, J ;
Chong, A ;
McCutcheon, S ;
Parnham, D ;
Eaton, S ;
MacKenzie, C ;
Houston, F .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :2897-2905